KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jan 14, 2019 $110.02 $110.33 $107.53 $107.58 1 681 793
Jan 11, 2019 $110.68 $111.53 $108.75 $111.13 1 339 548
Jan 10, 2019 $109.15 $111.49 $108.45 $110.93 1 467 699
Jan 09, 2019 $108.99 $110.74 $108.32 $109.96 1 553 265
Jan 08, 2019 $108.65 $110.49 $105.20 $108.61 1 766 466
Jan 07, 2019 $105.65 $108.98 $104.70 $107.94 1 983 675
Jan 04, 2019 $101.88 $107.30 $101.80 $106.00 2 349 942
Jan 03, 2019 $100.15 $103.88 $99.12 $100.21 3 296 547
Jan 02, 2019 $95.84 $99.05 $95.16 $98.05 1 359 749
Dec 31, 2018 $98.06 $99.81 $96.39 $97.36 1 310 388
Dec 28, 2018 $98.52 $99.27 $96.57 $97.21 1 407 224
Dec 27, 2018 $95.83 $98.19 $93.79 $98.10 1 466 702
Dec 26, 2018 $94.95 $97.87 $94.04 $97.87 1 945 266
Dec 24, 2018 $93.23 $96.57 $92.56 $93.94 1 774 805
Dec 21, 2018 $101.19 $102.37 $93.67 $94.63 5 336 786
Dec 20, 2018 $102.07 $105.02 $99.75 $101.22 2 959 329
Dec 19, 2018 $106.39 $107.72 $100.93 $102.78 2 526 742
Dec 18, 2018 $110.13 $110.74 $105.41 $105.99 2 012 300
Dec 17, 2018 $109.36 $114.07 $108.21 $109.53 2 159 290
Dec 14, 2018 $111.59 $112.24 $108.86 $109.43 2 120 832
Dec 13, 2018 $117.27 $118.26 $112.33 $112.43 2 564 620
Dec 12, 2018 $117.24 $118.76 $116.00 $117.01 1 395 861
Dec 11, 2018 $115.96 $117.11 $113.28 $114.83 1 403 453
Dec 10, 2018 $115.65 $115.99 $111.75 $114.65 1 670 714
Dec 07, 2018 $119.83 $120.98 $114.40 $115.60 1 229 654
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT